A system for vaccinating swine according to one embodiment includes a housing having an open first end and an open opposite second end. The housing has a pair of side walls that are angled and non-parallel to one another such that at the second end only a single piglet can exit at one time. The system also includes a vaccination station for individually vaccinating piglets. The vaccination station is located between the pair of side walls in a region thereof that is sized to only permit one piglet to stand between the side walls. The vaccination station includes at least one sensor that detects the presence of the one piglet within the vaccination station and at least one spray nozzle positioned within the vaccination station such that a vaccine dose discharged therefrom is directed upwardly into facial areas of the piglet effectively.

Antiseptic agent delivery systems and methods are provided, one such system comprising: a reservoir configured to store an antiseptic solution, wherein the antiseptic solution comprises an aqueous solution of hypochlorous acid; an ultrasound generator coupled to the reservoir, wherein the ultrasound generator vaporizes the antiseptic solution into an antiseptic vapor; a nozzle to direct the antiseptic vapor to an affected area; and a housing coupled to the reservoir and the nozzle, wherein the housing comprises a panel to control the ultrasound generator.

A Non-Rebreather Exhalation Filtration Device (FD) with a front plastic sheet (PS), an aerosol separator (AS) and optionally a collection reservoir (R) may be fitted (i) (FIG. 3A) by its inlet port (IP) onto a nebulizer exhaust tube (NET), or (ii) by an adhesive layer (AL) onto a respiratory mask (M) having a port (P) and a flat surface (FIG. 5), or (iii) by an adhesive layer (AL) and flexible substrate (FS) onto a respiratory mask (M) having a port (P) and a non-flat (FIG. 6) surface. A deflector (D), stiffener component (SC) and rear plastic sheet (PS2) are disclosed. Methods of using the Filtration Device are disclosed.

A Non-Rebreather Exhalation Filtration Device (FD) with a front plastic sheet (PS), an aerosol separator (AS) and optionally a collection reservoir (R) may be fitted (i) (FIG. 3A) by its inlet port (IP) onto a nebulizer exhaust tube (NET), or (ii) by an adhesive layer (AL) onto a respiratory mask (M) having a port (P) and a flat surface (FIG. 5), or (iii) by an adhesive layer (AL) and flexible substrate (FS) onto a respiratory mask (M) having a port (P) and a non-flat (FIG. 6) surface. A deflector (D), stiffener component (SC) and rear plastic sheet (PS2) are disclosed. Methods of using the Filtration Device are disclosed.

The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to an inhalation device having improved flow characteristics. A inhalation device for medically active liquids (F) for generation of an aerosol comprises a housing (1), inside this housing (1) a reservoir (2) for storing a liquid (F), a pumping device with a hollow cylinder (9) providing a pumping chamber (3) for the generation of a pressure inside said pumping chamber (3), wherein the pumping chamber is fluidically connected with the reservoir (2) via an inlet check valve (4) which blocks in direction of the reservoir (2), a riser pipe (5) which can be received with at least one reservoir-facing, interior end (5A) in said hollow cylinder (9), and a nozzle (6) which is connected liquid-tight to an exterior end (5B) of the riser pipe (5), wherein the volume of the pumping chamber (3) is changeable by means of relative motion of the cylinder (9) to the riser pipe (5), and is characterised in that the riser pipe (5) is immobile and firmly attached to the housing (1) and to the nozzle (6), whereas the hollow cylinder (9) is moveable relative to the housing (1) and to the nozzle (6). The invention also discloses a method for the generation of an aerosol of a medically active liquid (F) by means of an inhalation device.

The present invention relates to a composition for use in the treatment of onychomycosis and/or tinea pedis, the composition comprising a polymer capable of forming nanoparticles and terbinafine, or derivative or salt thereof, wherein the nanoparticles are formed with and/or in the presence of terbinafine, or derivative or salt thereof and wherein the composition is administered topically to provide a daily dose to an infected area in the range of about 5 μg to about 50 μg of terbinafine. The invention also relates to a combination of the composition and a liquid dispensing device for dispensing a pre-defined quantity of the composition to a user's toes and/or inter-digital spaces and/or front of the foot.

The spray application device with angled tip may comprise an applicator and an activator, where the applicator has a nozzle for delivery of a sprayable material. The spray application device may store a medication and may dispense the medication as an aerosol mist. The medication applicator may be adapted to dispense the medication through a nostril of a user directed at the posterior nasal cavity. The spray application device may be operable to release the medication in multiple doses of predetermined volume. The spray application device may be adapted for the user to self-administer the medication while positioned in any preferred physical position. A nozzle with a compliant nozzle shroud, an angled tip, and anatomically optimized nozzle geometry may direct the medication to a precise location within the posterior nasal cavity of a user.

An essential oil reflux-type atomizer comprising the following structures: chassis, housing, atomization chamber, gas pump, gas tube, gas nozzle, oil nozzle, and filter atomization mechanism. The filter atomization mechanism is installed in the housing and has an upper filter and a lower filter. The essential oil atomizer can be improved efficiency and reduced noise level.

The present invention relates to a device for delivering acetylsalicylic acid or a salt thereof for the administration thereof through oral inhalation route for the preventive or curative treatment of thrombohemolytic events, in particular for myocardial infarction.

The present invention provides methods for treating tumors in subjects by using a recombinant interferon (rSIFN-co), and optionally, methods for treating solid tumors, such as lung cancer, among others, with or without prior surgery, and as a first line or second line monotherapy or in combination with one or more other anti-tumor therapies. The present invention further provides non-surgical methods for eliminating tumors or reducing tumor sizes in subjects, and/or preventing postoperative tumor recurrence and/or metastases in subjects by using the recombinant interferon (rSIFN-co) which comprises a unique spatial configuration, alone or in conjunction with radiotherapy, chemotherapy, and/or one or more anti-tumor drugs such as biological agents, targeted drugs, small molecules, Traditional Chinese Medicine (TCM) and the like.